-+ 0.00%
-+ 0.00%
-+ 0.00%

Lake Street Maintains Buy on LifeMD, Lowers Price Target to $3

Benzinga·11/13/2026 21:02:50
Listen to the news
Lake Street analyst Ryan Meyers maintains LifeMD (NASDAQ:LFMD) with a Buy and lowers the price target from $5 to $3.